Skip to main content

MoneyWorks4Me

The quarter ended March 2024 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 68.28 millions.The Company to register a -74.08%  fall in the net profit for the quarter ended March 2024.Operating Profit reported a sharp decline to 14.82 millions from 17.85 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 68.28 68.26 0.03 272.97 197.67 38.09 272.97 197.67 38.09
Other Income 0.01 0.20 -95.00 0.06 0.34 -82.35 0.06 0.34 -82.35
PBIDT 14.82 17.85 -16.97 44.65 35.87 24.48 44.65 35.87 24.48
Interest 0.42 0.63 -33.33 1.94 2.35 -17.45 1.94 2.35 -17.45
PBDT 13.90 17.22 -19.28 42.21 33.52 25.92 42.21 33.52 25.92
Depreciation 2.56 1.04 146.15 10.44 6.16 69.48 10.44 6.16 69.48
PBT 11.34 16.18 -29.91 31.77 27.36 16.12 31.77 27.36 16.12
TAX 8.11 3.72 118.01 14.41 6.15 134.31 14.41 6.15 134.31
Deferred Tax 3.22 0.09 3477.78 3.22 0.09 3477.78 3.22 0.09 3477.78
PAT 3.23 12.46 -74.08 17.36 21.21 -18.15 17.36 21.21 -18.15
Equity 64.37 64.37 0.00 64.37 64.37 0.00 64.37 64.37 0.00
PBIDTM(%) 19.99 24.24 -17.53 15.04 16.77 -10.33 15.04 16.77 -10.33
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..